#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia refractory Leukaemia Neuroendocrine tumour of the lung Angiosarcoma recurrent Intracranial germ cell tumour Type IIa hyperlipidaemia C3 glomerulopathy Synovitis Short-bowel syndrome Chronic hepatitis B Neutropenia Neonatal alloimmune thrombocytopenia Cervix carcinoma recurrent B-cell lymphoma refractory Haemophilia B with anti factor IX More trials…

    Learn about Rare Diseases

    Cerebral arteriovenous malformation haemorrhagic Epidermolysis bullosa – Diagnostics Ehlers-Danlos syndrome – Life with Disease Marginal zone lymphoma refractory – Basic Information Pulmonary fibrosis – Life with Disease Metachromatic leukodystrophy – Life with Disease Turner’s syndrome – Diagnostics Anaplastic thyroid cancer – Life with Disease Myelodysplastic syndrome – Life with Disease Hereditary neuropathic amyloidosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSK4418959A Sacubitril Valsartan Hydrocortisone Abiraterone Acetate Dexamethasone Isonicotinate Metamizole Sodium Monohydrate Ace Inhibitors, Plain Azd2693 Sodium Sar-443579 Vancomycin Dexlansoprazole Deflazacort POTASSIUM HYDROXIDE Cytisine GSKVX000000030810 Codeine Phosphate Hemihydrate Indapamide Garadacimab INCB123667 Izorlisib Mesilate More therapies…

    Learn about Your Condition

    Rasmussen encephalitis Encephalitis Japanese B Chorioretinitis Cervix carcinoma stage II Inclusion body myositis Type V hyperlipidaemia Delirium Cluster headache Meniere's disease Cancer fatigue Transferrin decreased Corneal graft failure Subarachnoid haemorrhage Gastrointestinal disorder Rectal adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hodgkin’s disease

  • Study of nivolumab plus drug combination versus standard first-line therapy in patients with advanced Hodgkin lymphoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Brentuximab Vedotin
    • Vinblastine Sulfate
    • Dacarbazine
    Poland

  • Study on Triptorelin for Fertility Protection in Young Women and Teenagers Undergoing Chemotherapy for Breast Cancer, Leukemia, Lymphomas, and Sarcomas

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    • Ewing’s sarcoma
    • Soft tissue sarcoma
    Investigated Drugs:
    • Triptorelin
    Sweden

  • Study on the Safety of HSP-CAR30 Immunotherapy for Patients with Relapsed or Refractory CD30+ Hodgkin and Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    • Non-Hodgkin’s lymphoma refractory
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • HSP-CAR30
    • Fludarabine Phosphate
    • Cyclophosphamide Monohydrate
    Spain

  • Study of Pembrolizumab with Hyaluronidase for Patients with Relapsed or Refractory Hodgkin Lymphoma or Primary Mediastinal Large B-cell Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    • Hodgkin’s disease
    Investigated Drugs:
    • Pembrolizumab
    Germany Poland Spain

  • Title: Comparing Brentuximab Vedotin plus ESHAP versus ESHAP alone in treating patients with relapsed or refractory classical Hodgkin’s Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Brentuximab Vedotin
    Austria Croatia Greece Spain

  • Study of Atezolizumab and Drug Combination for Patients with Relapsed or Refractory Hodgkin’s Lymphoma Eligible for Stem Cell Transplant

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Vinorelbine
    • Vinorelbine Tartrate
    • Atezolizumab
    Italy
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!